Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report

Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report

Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case Reports in Oncology 2021-01, Vol.14 (1), p.430-438
Hauptverfasser: Guercio, Brendan John, Iyer, Gopa, Kidwai, Wajih Zaheer, Lacouture, Mario E., Ghafoor, Soleen, Rossi, Anthony M., Assis, David N., Chen, Ying-Bei, Busam, Klaus J., Janjigian, Yelena Y., Jhaveri, Komal, Feldman, Darren R., Capozzi, Anne, Figueroa, Vanessa, Bajorin, Dean F., Rosenberg, Jonathan E., Hollmann, Travis J., Funt, Samuel A.
Format: Artikel
Sprache:eng
Schlagworte:
Androgens
Bladder
Breast cancer
Cancer therapies
Case Report
Case reports
Case studies
Diagnosis
Dosage and administration
Drug therapy
extramammary paget disease
immune checkpoint blockade
Immunotherapy
Ipilimumab
Ligands
Medical prognosis
Metastasis
Monoclonal antibodies
Mutation
nivolumab
Prostate
Targeted cancer therapy
Testicular cancer
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival
ISSN:1662-6575
1662-6575
DOI:10.1159/000514345